Depressive Disorders - Mexico | Statista Market Forecast

Revenue in the Depressive Disorders market is projected to reach US$337.60m in 2024.
Revenue is expected to show an annual growth rate (CAGR 2024-2029) of 0.96%, resulting in a market volume of US$354.10m by 2029.
In global comparison, most revenue will be generated United States (US$6.26bn in 2024).
In relation to total population figures, per person revenues of US$54.49 are generated in 2024.

Depressive disorders are a common type of mental illness. Symptoms include depressive moods such as feeling sad, low concentration, low self-worth, loss of interest in activities, and, in some cases, thoughts of suicide. Common treatments for depressive disorders include psychological treatments such as psychotherapy, behavioral therapy, and antidepressant medication.

The Depressive Disorders market in the Mental Health market represents the market for antidepressant drug sales. Different types of antidepressants are usually prescribed for the treatment of mild to serious cases of depression, e.g., selective serotonin reuptake inhibitors (SSRIs), serotonin norepinephrine reuptake inhibitor (SNRIs), serotonin modulators, as well as tricyclic and tetracyclic antidepressants.

Market values represent the revenues generated by manufacturers and are based on retail prices for each drug category including all drugs, regardless of whether they are reimbursed or not.

Company examples: Novartis AG, Pfizer, Bristol-Myers Squibb, GlaxoSmithKline, Patheon Inc, and Sandoz Inc.

Antidepressant drugs
Selective serotonin reuptake inhibitors (SSRIs)
Serotonin norepinephrine reuptake inhibitor (SNRIs)
Serotonin modulators
Tricyclic and tetracyclic antidepressants

Psychotherapy
Mood stabilizers
Anti-anxiety and stimulant medications
Behavioral therapy

The Depressive Disorders market in Mexico has been experiencing significant growth in recent years.

Customer preferences: Mexican customers are increasingly seeking treatment for depressive disorders due to a growing awareness of mental health issues and a reduction in the stigma surrounding these conditions. They are more willing to seek professional help and are actively looking for effective treatments that can improve their quality of life. Additionally, there is a preference for personalized treatment plans that take into account individual needs and circumstances.

Trends in the market: One of the key trends in the Depressive Disorders market in Mexico is the increasing use of pharmaceutical interventions. Antidepressant medications are becoming more widely prescribed by healthcare professionals to manage depressive symptoms. This trend is driven by the efficacy and convenience of pharmaceutical treatments, as well as the availability of a wide range of antidepressant drugs in the market. Additionally, there is a growing demand for psychotherapy services, including cognitive-behavioral therapy and interpersonal therapy, as they are seen as effective complementary treatments to medication.

Local special circumstances: Mexico has a high prevalence of depressive disorders, which contributes to the growth of the market. The country faces various challenges that can contribute to the development of depressive symptoms, such as high levels of poverty, social inequality, and violence. These factors create a need for effective treatments and support services for individuals suffering from depressive disorders. Additionally, the Mexican healthcare system is increasingly recognizing the importance of mental health and is working towards improving access to mental health services.

Underlying macroeconomic factors: The growth of the Depressive Disorders market in Mexico is also influenced by underlying macroeconomic factors. The country has experienced steady economic growth in recent years, leading to an increase in disposable income and healthcare spending. This allows individuals to afford the cost of treatment for depressive disorders, including medication and therapy sessions. Furthermore, the Mexican government has implemented policies to improve mental health services and increase funding for mental health programs, which has contributed to the growth of the market.In conclusion, the Depressive Disorders market in Mexico is experiencing significant growth due to increasing customer preferences for effective treatments, the use of pharmaceutical interventions, and the availability of psychotherapy services. The high prevalence of depressive disorders in the country, along with the recognition of mental health as an important issue, has created a demand for treatments and support services. Additionally, the steady economic growth and government initiatives to improve mental health services have further fueled the growth of the market.

Data coverage:

Data encompasses B2C enterprises. Figures are based on companies' revenues, international institutes data, and global consumer survey data. Revenues refer to the retail value and include sales taxes.

Modeling approach / Market size:

Market sizes are determined by a combined top-down and bottom-up approach, based on a specific rationale for each market market. As a basis for evaluating markets, we use financial reports and third-party data. Next, we use relevant key market indicators and data from country-specific associations such as healthcare spending per capita, medical product spending per capita, and gross domestic product per capita. This data helps us to estimate the market size for each country individually.

Forecasts:

In our forecasts, we apply diverse forecasting techniques. The selection of forecasting techniques is based on the behavior of the particular market. For example, S-Curve function, ARIMA time series model and exponential curve function. Data is modeled using current exchange rates.

Additional Notes:

The market is updated twice per year in case market dynamics change. The impact of the COVID-19 pandemic is considered at a country-specific level. GCS data is reweighted for representativeness.

This report presents a comprehensive analysis and additional information on the Health market, in a PDF format.

Despite what some may think, mental health problems are common in the United States and around the world. Mental health issues, much like other health issues, can be mild, but can also be life altering, affecting the emotional, social, and psychological well-being of the person. Common types of mental illness include mood disorders, anxiety disorders, eating disorders, and personality disorders. Although symptoms of mental illness differ depending on the type of illness and seriousness of the problem, common symptoms of mental health issues include changes in sleeping and eating habits, social withdrawal, feelings of hopelessness, anger, and prolonged sadness, suicidal thoughts, and substance abuse. In 2022, it was estimated that around 36 percent of those in the U.S. aged 18 to 25 years and 29 percent of those aged 26 to 49 years suffered from some form of mental illness in the past year.